• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.

作者信息

Reznick R K, Langer B, Taylor B R, Seif S, Blendis L M

出版信息

Gastroenterology. 1983 Apr;84(4):713-8.

PMID:6337910
Abstract

Seven patients with persistent hyponatremia but normal or elevated serum arginine vasopressin levels and refractory ascites undergoing peritoneovenous shunting were studied in a Metabolic Unit on a 20 mEq sodium 1200 ml fluid-restricted diet to elucidate the mechanism of this response. The intravascular volume expansion after shunt implantation resulted in improvements in cardiac output, renal plasma flow and creatinine clearance (70.7 +/- 9.5 to 140.1 +/- 18.5 ml/min, p less than 0.005). There was an immediate diuresis (632 +/- 135 to 2450 +/- 323 ml/day, p less than 0.005) and natriuresis (3 +/- 1 to 25.9 +/- 10.6 mEq/24 h, p less than 0.05), and urine osmolality decreased significantly (622 +/- 91 to 251 +/- 76 mosmol/L, p less than 0.05) with a significant rise in serum sodium concentration by 72 hr (131 +/- 2 to 135 +/- 1.6 mEq/L, p less than 0.05) and serum osmolality. Serum arginine vasopressin levels remained elevated at 3.85 +/- 0.94 microU/ml, however, although a transient depression cannot be excluded. Subsequently, a small but significant decrease in serum arginine vasopressin levels to 3.04 +/- 0.65 microU/ml (p less than 0.05) was associated with a further rise in serum sodium levels above baseline values (138 +/- 1.4 mEq/L, p less than 0.01) and in serum osmolality. In conclusion, these results indicate that in this group of cirrhotic patients with refractory ascites, intrarenal factors, such as decreased delivery of filtrate to the distal nephron as well as elevated inappropriate levels of arginine vasopressin, are important in the pathogenesis of hyponatremia.

摘要

相似文献

1
Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.
Gastroenterology. 1983 Apr;84(4):713-8.
2
Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects.腹腔静脉分流术的肾脏和血流动力学效应。II. 长期效应。
Gastroenterology. 1981 Jan;80(1):119-25.
3
The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.利用腹腔静脉分流术阐明肝硬化腹水的发病机制。
Isr J Med Sci. 1986 Feb;22(2):78-80.
4
The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.经颈静脉肝内门体分流术治疗顽固性肝腹水的肾脏及血流动力学效应
Gastroenterology. 1979 Aug;77(2):250-7.
5
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.肝硬化难治性腹水:容量扩张和血浆心钠素水平升高的作用
Hepatology. 1993 Sep;18(3):519-28.
6
Improved renal function and inhibition of renin and aldosterone secretion following peritoneovenous (LeVeen) shunt.经腹腔-静脉(LeVeen)分流术后肾功能改善及肾素和醛固酮分泌受抑制。
Surgery. 1978 Jul;84(1):120-6.
7
Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.口服血管加压素V2受体拮抗剂VPA - 985纠正肝硬化或抗利尿激素分泌不当综合征低钠血症患者期间溶质排泄的差异。
J Lab Clin Med. 2001 Jul;138(1):18-21. doi: 10.1067/mlc.2001.116025.
8
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.一种血管加压素受体拮抗剂(VPA - 985)可改善低钠血症患者的血清钠浓度:一项多中心、随机、安慰剂对照试验。
Hepatology. 2003 Jan;37(1):182-91. doi: 10.1053/jhep.2003.50021.
9
Whole-body volume regulation and escape from antidiuresis.全身容量调节与抗利尿状态的解除。
Am J Med. 2006 Jul;119(7 Suppl 1):S21-9. doi: 10.1016/j.amjmed.2006.05.004.
10
Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage.高血容量疗法可预防蛛网膜下腔出血后的容量收缩,但不能预防低钠血症。
Ann Neurol. 1992 May;31(5):543-50. doi: 10.1002/ana.410310513.

引用本文的文献

1
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.肝硬化代偿良好患者的钠代谢取决于肝脏疾病的严重程度和门静脉压力。
Gut. 2000 Apr;46(4):527-33. doi: 10.1136/gut.46.4.527.